Format
Sort by

Send to

Choose Destination

Search results

Items: 1 to 20 of 79

1.

Author reply.

Nikpour M, Prior D, Proudman S, Stevens W.

Intern Med J. 2016 Jun;46(6):751-2. doi: 10.1111/imj.13100. No abstract available.

PMID:
27257157
2.

The role of asymmetric dimethylarginine alone and in combination with N-terminal pro-B-type natriuretic peptide as a screening biomarker for systemic sclerosis-related pulmonary arterial hypertension: a case control study.

Thakkar V, Stevens W, Prior D, Rabusa C, Sahhar J, Walker JG, Roddy J, Lester S, Rischmueller M, Zochling J, Nash P, Gabbay E, Youssef P, Proudman SM, Nikpour M.

Clin Exp Rheumatol. 2016 May 23. [Epub ahead of print]

PMID:
27214686
3.
4.

Mycophenolate mofetil is an effective and safe option for the management of systemic sclerosis-associated interstitial lung disease: results from the Australian Scleroderma Cohort Study.

Owen C, Ngian GS, Elford K, Moore O, Stevens W, Nikpour M, Rabusa C, Proudman S, Roddy J, Zochling J, Hill C, Sturgess A, Tymms K, Youssef P, Sahhar J.

Clin Exp Rheumatol. 2016 Mar 24. [Epub ahead of print]

PMID:
27049330
5.

The Impact of Turmeric Cream on Healing of Caesarean Scar.

Mahmudi G, Nikpour M, Azadbackt M, Zanjani R, Jahani MA, Aghamohammadi A, Jannati Y.

West Indian Med J. 2015 Sep;64(4):400-6. doi: 10.7727/wimj.2014.196. Epub 2015 Jun 30.

PMID:
26624595
6.

The Effectiveness of Prenatal Intervention on Pain and Anxiety during the Process of Childbirth-Northern Iran: Clinical Trial Study.

Firouzbakht M, Nikpour M, Khefri S, Jamali B, Kazeminavaee F, Didehdar M.

Ann Med Health Sci Res. 2015 Sep-Oct;5(5):348-52. doi: 10.4103/2141-9248.165260.

7.

Definition and initial validation of a Lupus Low Disease Activity State (LLDAS).

Franklyn K, Lau CS, Navarra SV, Louthrenoo W, Lateef A, Hamijoyo L, Wahono CS, Chen SL, Jin O, Morton S, Hoi A, Huq M, Nikpour M, Morand EF; Asia-Pacific Lupus Collaboration.

Ann Rheum Dis. 2015 Oct 12. pii: annrheumdis-2015-207726. doi: 10.1136/annrheumdis-2015-207726. [Epub ahead of print]

PMID:
26458737
8.

Intravenous cyclophosphamide as a therapeutic option for severe refractory gastric antral vascular ectasia in systemic sclerosis.

Papachristos DA, Nikpour M, Hair C, Stevens WM.

Intern Med J. 2015 Oct;45(10):1077-81. doi: 10.1111/imj.12883.

PMID:
26429218
9.

Cost savings with a new screening algorithm for pulmonary arterial hypertension in systemic sclerosis.

Quinlivan A, Thakkar V, Stevens W, Morrisroe K, Prior D, Rabusa C, Youssef P, Gabbay E, Roddy J, Walker JG, Zochling J, Sahhar J, Nash P, Lester S, Rischmueller M, Proudman SM, Nikpour M.

Intern Med J. 2015 Nov;45(11):1134-40. doi: 10.1111/imj.12890.

PMID:
26337683
10.

Clinical correlates of monospecific anti-PM75 and anti-PM100 antibodies in a tri-nation cohort of 1574 systemic sclerosis subjects.

Wodkowski M, Hudson M, Proudman S, Walker J, Stevens W, Nikpour M, Assassi S, Mayes MD, Tatibouet S, Wang M; Canadian Scleroderma Research Group (CSRG); Australian Scleroderma Interest Group (ASIG); Genetics versus Environment in Scleroderma Outcome Study (GENISOS), Baron M, Fritzler MJ.

Autoimmunity. 2015;48(8):542-51. doi: 10.3109/08916934.2015.1077231. Epub 2015 Aug 31.

PMID:
26334795
11.

Monospecific anti-Ro52/TRIM21 antibodies in a tri-nation cohort of 1574 systemic sclerosis subjects: evidence of an association with interstitial lung disease and worse survival.

Wodkowski M, Hudson M, Proudman S, Walker J, Stevens W, Nikpour M, Assassi S, Mayes MD, Wang M, Baron M, Fritzler MJ; Canadian Scleroderma Research Group (CSRG); Australian Scleroderma Cohort Study (ASCS); Genetics versus Environment in Scleroderma Outcome Study (GENISOS).

Clin Exp Rheumatol. 2015 Jul-Aug;33(4 Suppl 91):S131-5. Epub 2015 Aug 27.

PMID:
26315678
12.

Interpretation of an Extended Autoantibody Profile in a Well-Characterized Australian Systemic Sclerosis (Scleroderma) Cohort Using Principal Components Analysis.

Patterson KA, Roberts-Thomson PJ, Lester S, Tan JA, Hakendorf P, Rischmueller M, Zochling J, Sahhar J, Nash P, Roddy J, Hill C, Nikpour M, Stevens W, Proudman SM, Walker JG.

Arthritis Rheumatol. 2015 Dec;67(12):3234-44. doi: 10.1002/art.39316.

PMID:
26246178
13.

Quantifying change in pulmonary function as a prognostic marker in systemic sclerosis-related interstitial lung disease.

Moore OA, Proudman SM, Goh N, Corte TJ, Rouse H, Hennessy O, Morrisroe K, Thakkar V, Sahhar J, Roddy J, Youssef P, Gabbay E, Nash P, Zochling J, Stevens W, Nikpour M.

Clin Exp Rheumatol. 2015 Jul-Aug;33(4 Suppl 91):S111-6. Epub 2015 Aug 5.

PMID:
26243401
14.

Musculoskeletal Manifestations of Systemic Sclerosis.

Morrisroe KB, Nikpour M, Proudman SM.

Rheum Dis Clin North Am. 2015 Aug;41(3):507-18. doi: 10.1016/j.rdc.2015.04.011. Epub 2015 May 26. Review.

PMID:
26210132
15.

On the Importance of C-H/π and C-H⋅⋅⋅H-C Interactions in the Solid State Structure of 15-Lipoxygenase Inhibitors Based on Eugenol Derivatives.

Mirzaei M, Nikpour M, Bauzá A, Frontera A.

Chemphyschem. 2015 Jul 20;16(10):2260-6. doi: 10.1002/cphc.201500287. Epub 2015 May 26.

PMID:
26014302
16.

Association of low vitamin D with high disease activity in an Australian systemic lupus erythematosus cohort.

Yap KS, Northcott M, Hoi AB, Morand EF, Nikpour M.

Lupus Sci Med. 2015 Apr 8;2(1):e000064. doi: 10.1136/lupus-2014-000064. eCollection 2015.

17.

Prospects for improving outcomes in systemic sclerosis-related pulmonary hypertension.

Thakkar V, Nikpour M, Stevens WM, Proudman SM.

Intern Med J. 2015 Mar;45(3):248-54. doi: 10.1111/imj.12691. Review.

PMID:
25735576
18.

A comparison of the predictive accuracy of three screening models for pulmonary arterial hypertension in systemic sclerosis.

Hao Y, Thakkar V, Stevens W, Morrisroe K, Prior D, Rabusa C, Youssef P, Gabbay E, Roddy J, Walker J, Zochling J, Sahhar J, Nash P, Lester S, Rischmueller M, Proudman SM, Nikpour M.

Arthritis Res Ther. 2015 Jan 18;17:7. doi: 10.1186/s13075-015-0517-5.

19.

Shb deficiency in endothelium but not in leucocytes is responsible for impaired vascular performance during hindlimb ischaemia.

Nikpour M, Gustafsson K, Vågesjö E, Seignez C, Giraud A, Phillipson M, Welsh M.

Acta Physiol (Oxf). 2015 Jun;214(2):200-9. doi: 10.1111/apha.12448. Epub 2015 Jan 17.

PMID:
25561022
20.

Potential role of the lectin pathway of complement in the pathogenesis and disease manifestations of systemic sclerosis: a case-control and cohort study.

Osthoff M, Ngian GS, Dean MM, Nikpour M, Stevens W, Proudman S, Eisen DP, Sahhar J.

Arthritis Res Ther. 2014 Nov 18;16(6):480. doi: 10.1186/s13075-014-0480-6.

Items per page

Supplemental Content

Loading ...
Write to the Help Desk